Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation
- PMID: 15548805
- PMCID: PMC1772433
- DOI: 10.1136/bjo.2004.044768
Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation
Abstract
Background/aims: In uveal melanoma monosomy 3 is emerging as a significant indicator of a poor prognosis. To date most cytogenetic studies of uveal melanoma have utilised fresh tissue or DNA extracted from tissue sections. In this study chromosome in situ hybridisation (CISH) was used to study monosomy 3 in tissue sections. The copy number of chromosome 3 was determined and related to patient survival.
Methods: Archival glutaraldehyde or formalin fixed, paraffin embedded material was obtained from 30 metastasising and 26 non-metastasising choroidal melanomas. Hybridisations were performed using centromere specific probes to chromosomes 3 and 18. Chromosome 18 was included as a control as previous abnormalities in uveal melanoma have not been described. Chromosomal imbalance was defined on the basis of changes in both chromosome index and signal distribution.
Results: CISH was successfully performed on both glutaraldehyde and formalin fixed tissue. Four cases were unsuccessful because of extensive tumour necrosis. All cases were balanced for chromosome 18. Monosomy 3 was detected in 15 of the 26 cases of metastasising melanoma; the 26 non-metastasising tumours were all balanced for chromosome 3. Monosomy 3 was significantly associated with metastases related death.
Conclusion: CISH can successfully identify monosomy 3 in archival glutaraldehyde or formalin fixed, paraffin embedded tissue sections. Similar to previous studies monosomy 3 is a significant predictor of metastases related death.
Figures
References
-
- Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973–1997. Ophthalmol 2003;110:956–61. - PubMed
-
- Diener-West M , Hawkins BS, Markowitz JA, et al. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 1992;110:245–50. - PubMed
-
- Bergman L , Seregard S, Nilsson B, et al. Uveal melanoma survival in Sweden from 1960 to 1998. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Invest Ophthalmol Vis Sci 2003;44:3282–7. - PubMed
-
- Kath R , Hayungs J, Bornfeld N, et al. Prognosis and treatment of disseminated uveal melanoma. Cancer 1993;72:2219–23. - PubMed
-
- Newton FH. Malignant melanoma of choroid. Report of a case with clinical history of 36 years and follow up of 32 years. Arch Ophthalmol 1965;73:198–9. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical